Francesca Ceccherini-Silberstein

发表

Characterization of Novel HIV Drug Resistance Mutations Using Clustering, Multidimensional Scaling and SVM-Based Feature Ranking

Thomas Lengauer, Niko Beerenwinkel, Hauke Walter, 2005, PKDD.

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, P. Narciso, 2004, The Journal of infectious diseases.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution.

Valentina Svicher, Jens Verheyen, Valeria Micheli, 2013, The Journal of general virology.

392 SPECIFIC HBSAG GENETIC-DETERMINANTS ARE ASSOCIATED WITH OCCULT HBV-INFECTION IN VIVO AND HBSAG-DETECTION

Valentina Svicher, Valeria Micheli, Francesca Ceccherini-Silberstein, 2011 .

Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients.

Stefano Alcaro, Anna Artese, Vitaliano Chiarella, 2010, Current medicinal chemistry.

Characterization and Structural Analysis of Novel Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involved in the Regulation of Resistance to Nonnucleoside Inhibitors

Thomas Lengauer, Stefano Alcaro, Jan Balzarini, 2007, Journal of Virology.

Identification and Structural Characterization of Novel Genetic Elements in the HIV-1 V3 Loop Regulating Coreceptor Usage

Stefano Alcaro, Giorgio Palù, Anna Artese, 2011, Antiviral therapy.

Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, C. Perno, 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Characterization and structural analysis of HIV-1 integrase conservation.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, A. Antinori, 2009, AIDS reviews.

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Valentina Svicher, Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, 2005, Antimicrobial Agents and Chemotherapy.

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors

Stefano Alcaro, Anna Artese, Lucia Parrotta, 2012, PloS one.

Historical resistance profile helps to predict salvage failure

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, P. Narciso, 2009, Antiviral therapy.

Key genetic elements in HIV-1 gp120 V1,V2 and C4 domains tightly and differentially modulate gp120 interaction with the CCR5 and CXCR4 N terminus and HIV-1 antigenetic Potential

Anna Artese, Lucia Parrotta, Giosuè Costa, 2011 .

Additional Mutations in HIV-1 Reverse Transcriptase are Involved in the Highly Ordered Regulation of NRTI Resistance

Niko Beerenwinkel, Federico Gago, Tobias Sing, 2005 .

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.

Valentina Svicher, Jens Verheyen, Valeria Micheli, 2012, Antiviral research.

Novel drug resistance mutations in HIV: recognition and clinical relevance.

Valentina Svicher, Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, 2006, AIDS reviews.

HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.

Jeroen Aerssens, Valentina Svicher, Loredana Sarmati, 2011, Antiviral research.